S
Market Data
$2.17−$0.20 (−8.44%)
SPRO · Last trade
Prev Close
$2.37
Range (30d)
$2.14 – $2.42
Recent Filings
- 8-K138.0 KBSpero Therapeutics, Inc.Jan 30, 5:01 PM ET·0001193125-26-032004
- 8-K143.2 KBSpero Therapeutics, Inc.Dec 19, 8:25 AM ET·0001193125-25-325821
- 8-K9.1 MBSpero Therapeutics, Inc.Nov 13, 5:18 PM ET·0001193125-25-280518
- 10-Q10.0 MBSpero Therapeutics, Inc.Nov 13, 4:10 PM ET·0001193125-25-280174
- 10-Q9.8 MBSpero Therapeutics, Inc.Aug 12, 4:31 PM ET·0000950170-25-107388
- 8-K2.8 MBSpero Therapeutics, Inc.Aug 12, 4:17 PM ET·0001193125-25-178970
- 8-K152.6 KBSpero Therapeutics, Inc.Jun 18, 5:12 PM ET·0001193125-25-142807
- 8-K177.1 KBSpero Therapeutics, Inc.May 28, 7:12 AM ET·0001193125-25-128680
- 8-K197.6 KBSpero Therapeutics, Inc.May 13, 4:49 PM ET·0001193125-25-118882
- 10-Q8.9 MBSpero Therapeutics, Inc.May 13, 4:15 PM ET·0000950170-25-070380
Insiders
10- Alphabet Inc.10% Owner
- Aquilo Capital, L.P.10% Owner
- Aquilo Capital Management, LLC10% Owner
- Atlas Venture Associates IX, LLC10% Owner
- Atlas Venture Associates IX, L.P.10% Owner
- Atlas Venture Fund IX, L.P.10% Owner
- Breum CasperDirector
- Deshpande MilindDirector
- DiPalma Stephen J.Interim CFO
- FORMELA JEAN FRANCOISDirector
Tickers
Addresses
business
675 MASSACHUSETTS AVENUE 14TH FLOOR
CAMBRIDGE, MA, 02139
mailing
675 MASSACHUSETTS AVENUE 14TH FLOOR
CAMBRIDGE, MA, 02139
Former Names
- Spero Therapeutics, LLC2017-03-21